title: Movement Disorders From the Use of Metoclopramide and Other Antiemetics in the Treatment of Migraine.
abstract: Nausea and vomiting are a frequent accompaniment of migraine and anti-nausea medications are frequently used in its management. The majority of anti-nausea medications that are used in migraine are dopamine receptor blocking agents and therefore have the potential to cause drug-induced movement disorders. This article explores the risk of such drug-induced movement disorders in migraineurs who were treated with these medications.
authors.affiliation: Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX, USA.
authors.forename: Subhashie
authors.initials: S
authors.lastname: Wijemanne
authors.affiliation: Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX, USA.
authors.forename: Joseph
authors.initials: J
authors.lastname: Jankovic
authors.affiliation: Department of Neurology, Baylor College of Medicine, Houston, TX, USA.
authors.forename: Randolph W
authors.initials: RW
authors.lastname: Evans
mesh_terms: D000328:Adult; D004087:Dihydroergotamine / Q000009:adverse effects*; D018491:Dopamine Agonists / Q000009:adverse effects*; D065127:Dopamine D2 Receptor Antagonists / Q000009:adverse effects*; D005104:Expert Testimony; D005260:Female; D006801:Humans; D008787:Metoclopramide / Q000009:adverse effects*; D008881:Migraine Disorders / Q000188:drug therapy; D009069:Movement Disorders / Q000209:etiology*
chemical_list: D018491:Dopamine Agonists; D065127:Dopamine D2 Receptor Antagonists; D004087:Dihydroergotamine; D008787:Metoclopramide
keywords: acute dystonic reaction; akathisia; metoclopramide; migraine; prochlorperazine; promethazine; tardive dyskinesia